AC Immune SA
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
8.55-6.0162.277.09
Price/Sales ratio
1.603.701.031.14
Earnings per Share (EPS)
$0.25$-0.36$0.03$0.31

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
80.2442.77-93.24-28.09-11.2812.80-5.30-4.63-2.22-6.56-2.38-11.28
Price/Sales ratio
28.4822.1828.5036.6379.915.2321.33N/A40.0324.0542.935.23
Price/Book Value ratio
36.7312.204.646.353.232.131.521.450.932.210.992.13
Price/Cash Flow ratio
-48.9119.66-117.19-33.58-13.0410.53-5.53-5.14-2.14-5.89-2.29-13.04
Price/Free Cash Flow ratio
-48.5619.77-101.09-31.05-12.5110.90-5.37-4.95-2.10-5.81-2.25-12.51
Price/Earnings Growth ratio
-0.470.450.67-0.12-0.14-0.070.02-0.360.170.26-0.18-0.07
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
46.75%56.38%-11.02%-61.25%-515.47%54.57%-285.50%N/A-1433.31%-268.93%N/A-515.47%
Operating Profit Margin
35.40%47.64%-45.04%-111.27%-688.76%40.11%-396.99%N/A-1800.43%-362.29%-1800.48%40.11%
Pretax Profit Margin
35.49%51.85%-30.56%-130.39%-708.24%40.92%-401.27%N/A-1797.71%-366.34%-1797.78%40.92%
Net Profit Margin
35.49%51.85%-30.56%-130.39%-708.24%40.92%-402.46%N/A-1798.04%-366.41%-1798.11%40.92%
Effective Tax Rate
0.28%8.10%-50.95%-0.55%2.16%4.16%-0.29%-0.00%-0.01%-0.01%-0.01%4.16%
Return on Assets
35.46%25.35%-4.54%-20.00%-25.92%15.18%-26.01%-27.92%-38.05%-29.66%-38.05%15.18%
Return On Equity
45.78%28.53%-4.98%-22.60%-28.68%16.67%-28.82%-31.46%-41.86%-33.76%-36.47%16.67%
Return on Capital Employed
41.41%25.22%-7.15%-18.43%-27.00%15.80%-27.26%-32.72%-40.61%-31.68%-40.61%15.80%
Liquidity Ratios
Current Ratio
N/AN/A15.6113.2814.7416.7216.53N/AN/AN/A11.1516.72
Quick Ratio
6.6412.6015.5713.4114.7416.8016.6710.1811.159.2110.7416.80
Cash ratio
0.7412.5415.3412.7511.9611.0511.474.102.755.782.7511.05
Days of Sales Outstanding
313.372.9522.1066.98208.123.5937.63N/A74.20371.0474.203.59
Days of Inventory outstanding
7.2452.685.50-15.18N/A-10.12-11.78-8.220.00N/AN/AN/A
Operating Cycle
320.6255.6327.6151.79208.12-6.5225.85N/A74.20371.04N/A-6.52
Days of Payables Outstanding
35.8736.8057.1412.2016.311.0213.4011.735.6111.22N/A1.02
Cash Conversion Cycle
284.7418.83-29.5239.59191.80-7.5512.45N/A68.58359.81N/A-7.55
Debt Ratios
Debt Ratio
N/AN/AN/A0.000.000.00N/AN/AN/AN/A0.090.00
Debt Equity Ratio
N/AN/AN/A0.000.000.00N/AN/AN/AN/A0.100.00
Long-term Debt to Capitalization
N/AN/AN/A0.000.00N/AN/AN/AN/AN/A0.010.00
Total Debt to Capitalization
N/AN/AN/A0.000.000.00N/AN/AN/AN/A0.010.00
Interest Coverage Ratio
N/AN/A-3.11-153.32184.2023.51-332.93N/AN/AN/A-199.0123.51
Cash Flow to Debt Ratio
N/AN/AN/A-44.72-85.0984.69N/AN/AN/AN/A-26.26-85.09
Company Equity Multiplier
1.291.121.091.121.101.091.101.121.101.131.101.09
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.581.12-0.24-1.09-6.120.49-3.85N/A-18.69-4.08-18.690.49
Free Cash Flow / Operating Cash Flow Ratio
1.000.991.151.081.040.961.021.041.011.011.010.96
Cash Flow Coverage Ratio
N/AN/AN/A-44.72-85.0984.69N/AN/AN/AN/A-26.26-85.09
Short Term Coverage Ratio
N/AN/AN/AN/A-132.7684.69N/AN/AN/AN/A-134.2484.69
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A